A new treatment approach to remediation developed by H2Plus targets PFAS bonds specifically to provide more comprehensive ...

Changing how biopharmas package their products, how regulators review new drugs and how mutated genes are fixed could make ...

Australian researchers have developed an implantable electronic device that has successfully restored movement in animals ...

Doctors administered an ultra-high dose of radioactive 131-Iodine MIBG therapy, making it the highest dosage ever used in ...

Phase 3 Aspire study enrollment on track to complete in 2025 Aurora study to evaluate GTX-102 in other Angelman syndrome genotypes and ages expected to initiate later this year NOVATO, Calif., June 27 ...

Investing.com -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) stock gained 2.2% premarket after the company announced that its experimental treatment for Angelman syndrome received Breakthrough ...

Clinical application: Treatment in a mouse model with milciclib in combination with mirvetuximab significantly reduced tumor ...

Just four days after its official launch on Amazon U.S., COSRX's Peptide-132 Ultra Perfect Hair Bonding Treatment has already claimed the top spot as the #1 New Release in the Deep Hair Conditioners ...

The newly licensed drug, leniolisib, is the first targeted treatment for her condition, Activated PI3-kinase Delta Syndrome ...

Researchers at Chalmers University of Technology in Sweden and the University of Auckland in New Zealand have developed a ...

Samsung’s tipped to reveal a much improved version of its book-style foldable phone at its upcoming Galaxy Unpacked event on ...

Bedfordshire Hospitals NHS Foundation Trust is now offering a cutting-edge, minimally invasive procedure for kidney stone ...